Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Joseph Elan Grossman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2130-2783; OpenAlex author ID A5073582280. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 2 papers

Papers 4

  1. A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer. Co-author DOI 10.7554/elife.87369↗
  2. A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer Co-author DOI 10.7554/elife.87369.3↗
  3. Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-4116↗
  4. Facts and Hopes in Immunotherapy of Pancreatic Cancer. First author DOI 10.1158/1078-0432.ccr-21-3452↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bruno Bockorny · 4 shared papers, 2022–2024 · strength 0.71
  2. Andrea J. Bullock · 3 shared papers, 2022–2024 · strength 0.45
  3. Ling Huang · 3 shared papers, 2022–2024 · strength 0.45
  4. Leo L. Tsai · 3 shared papers, 2022–2024 · strength 0.45
  5. Senthil K. Muthuswamy · 3 shared papers, 2022–2024 · strength 0.45
  6. Mandeep Sawhney · 3 shared papers, 2022–2024 · strength 0.45
  7. Manuel M. Hidalgo · 2 shared papers, 2022 · strength 0.37
  8. Steven D. Freedman · 2 shared papers, 2024 · strength 0.33
  9. Mary Linton B. Peters · 1 shared paper, 2022 · strength 0.11
  10. Mark P. Callery · 1 shared paper, 2022 · strength 0.11
  11. Raul S. González · 1 shared paper, 2022 · strength 0.11
  12. Tara Sotsky Kent · 1 shared paper, 2022 · strength 0.11
  13. Douglas K. Pleskow · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.